Making the Case for Medicaid Funding of Smoking Cessation Treatment Programs: An Application to State-Level Health Care Savings

2014 ◽  
Vol 25 (4) ◽  
pp. 1922-1940 ◽  
Author(s):  
Debra Moehle McCallum ◽  
Gabriel H. Fosson ◽  
Maria Pisu
Keyword(s):  
Health Care ◽  
Smoking Cessation ◽  
State Level ◽  
Treatment Programs ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment

scholarly journals Identifying Barriers to Entering Smoking Cessation Treatment Among Socioeconomically Disadvantaged Smokers

2010 ◽  
Vol 5 (2) ◽  
pp. 164-171 ◽  
Author(s):  
Amy L. Copeland ◽  
Michael S. Businelle ◽  
Diana W. Stewart ◽  
Scott M. Patterson ◽  
Carla J. Rash ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Nicotine Dependence ◽  
Stage Of Change ◽  
Psychosocial Treatment ◽  
Treatment Programs ◽  
Smoking Rate ◽  
Socioeconomically Disadvantaged ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment ◽  
Professional Assistance

AbstractBackground:Efficacious smoking cessation interventions exist, yet few smokers utilise available resources such as psychosocial treatment programs and pharmacotherapy. The goals of the present study were to (1) identify perceived barriers to entering smoking cessation treatment programs among socioeconomically disadvantaged smokers, who are presently underrepresented in smoking cessation interventions; (2) determine what variables are most important in predicting the barriers identified (i.e., age, gender, ethnicity, income, nicotine dependence level, smoking rate, years smoking, stage of change, presence of smoking-related illness and medical insurance status).Methods:Responses from socioeconomically disadvantaged smokers (N= 343) were collected in 2004–2005 and analysed to develop the Treatment Barriers Questionnaire, a 40-item measure of reasons for not entering smoking cessation programs. Study methods were approved by the Institutional Review Board of Louisiana State University; informed consent procedures were employed.Results:Principal components analysis yielded seven scales named for their theme: (1) Preparedness to Quit Smoking; (2) Work and Time Constraints; (3) Smokers Can or Should Quit on Own; (4) Opinions about Professional Assistance; (5) Mobility Limitations; (6) Insurance Limitations and (7) Misinformation about Professional Assistance. Gender, ethnicity, daily smoking rate, nicotine dependence and stage of change were significant predictors in regression analyses for scales 1,F(10, 201) = 7.83,p< .001,R2= .29, 2F(10, 201) = 2.30,p< .05,R2= .11, and 3,F(10, 201) = 3.58,p< .001,R2= .16. Conclusions: Results can inform efforts to facilitate entry and retention of smokers in cessation programs.

scholarly journals Safety Net Provider Attitudes Toward Smoking Cessation Treatment

2021 ◽  
Vol 12 ◽  
Author(s):  
Lindsay R. Meredith ◽  
Wave-Ananda Baskerville ◽  
Theodore C. Friedman ◽  
Brian Hurley ◽  
Tasha Dixon ◽  
...  
Keyword(s):  
Health Care ◽  
Smoking Cessation ◽  
Tobacco Use ◽  
Large Scale ◽  
Safety Net ◽  
Care Providers ◽  
Provider Attitudes ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment ◽  
Treatment Attitudes

Background: Cigarette smoking, which poses significant health risks, is prevalent among vulnerable populations commonly treated by safety net providers. A large-scale implementation science project on specialty tobacco use treatment was launched within the Los Angeles County Health Agency. The first phase of this study seeks to summarize and compare smoking cessation treatment attitudes of providers at the Department of Health Services (DHS) and Department of Mental Health (DMH).Methods: In total, 467 safety net health care providers (DHS = 322; DMH = 145) completed a survey inquiring about attitudes on smoking cessation treatment consisting of locally developed items and those informed by a scale on readiness for organizational change. Descriptive statistics and non-parametric tests were conducted to examine treatment attitudes for DHS and DMH providers.Results: Between agencies, providers largely reported similar attitudes on smoking cessation treatment and expressed positive beliefs regarding the efficacy of smoking cessation aids. Providers slightly or moderately agreed with being prepared to identify and diagnose tobacco use among patients. DMH providers stated that identification of tobacco use was less in line with their job responsibilities (p &lt; 0.0001) and less strongly agreed that varenicline is effective for smoking cessation (p = 0.003), compared with DHS providers.Conclusions: Providers supported smoking cessation aid efficacy but may benefit from additional training on identification and treatment of tobacco use. These findings support the implementation of specialty tobacco cessation treatment programs with training on medications in safety net health care systems, which has the potential to yield large-scale public health benefits.

scholarly journals Smoking Cessation Treatment Programs Offered at Hospitals Providing Oncology Services

2018 ◽  
Vol 14 (1) ◽  
pp. 65-71 ◽  
Author(s):  
Michael Shayne Gallaway ◽  
Eric Tai ◽  
Elizabeth A. Rohan
Keyword(s):  
Smoking Cessation ◽  
Tobacco Cessation ◽  
Treatment Programs ◽  
Treatment Cessation ◽  
Smoking Cessation Treatment ◽  
Treatment Services ◽  
Tobacco Treatment ◽  
Cessation Treatment ◽  
Quit Attempts ◽  
Discharged Patients

Background: Many people with cancer continue smoking despite evidence that it negatively effects cancer treatment, worsens chemotherapy toxicity, and increases risk for a second cancer.Aims: We examined tobacco treatment services offered to cancer patients at hospitals providing oncology services, including National Cancer Institute (NCI)-Designated Cancer Centers (NDCCs).Methods: We examined survey data of 6,400 U.S. hospitals from 2008 to 2015 to determine the manner in which tobacco treatment/cessation program services were provided among NDCCs and non-NDCC hospitals providing oncology services (HPOs).Results: From 2008 to 2015, 784 responses from NDCCs and 18,281 responses from HPOs were received. NDCCs (86%) reported significantly higher tobacco treatment/cessation programs owned by the hospital compared to HPOs (68%) (p < 0.001). Among NDCCs, there was a significant increasing trend of tobacco treatment/cessation programs reported owned by the hospital, the health system, or other contractual mechanism from 2008 to 2015 (p = 0.03).Conclusions: More than 80% of oncology providing hospitals report providing tobacco cessation programs, with higher percentages reported in NDCCs. As hospitals implement smoking cessation programs, partnerships between hospitals and cancer coalitions could help bring tobacco cessation activities to communities they both serve, and link discharged patients to these cessation resources so they can continue quit attempts that they initialised while hospitalised.

scholarly journals Evaluation of smoking cessation treatment initiated during hospitalization in patients with heart disease or respiratory disease

2018 ◽  
Vol 44 (1) ◽  
pp. 42-48 ◽  
Author(s):  
Thaís Garcia ◽  
Sílvia Aline dos Santos Andrade ◽  
Angélica Teresa Biral ◽  
André Luiz Bertani ◽  
Laura Miranda de Oliveira Caram ◽  
...  
Keyword(s):  
Health Care ◽  
Smoking Cessation ◽  
Heart Disease ◽  
Hospital Discharge ◽  
Respiratory Disease ◽  
Health Care Professionals ◽  
Smoking Cessation Program ◽  
Cognitive Behavioral ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment

ABSTRACT Objective: To evaluate the effectiveness of a smoking cessation program, delivered by trained health care professionals, in patients hospitalized for acute respiratory disease (RD) or heart disease (HD). Methods: Of a total of 393 patients evaluated, we included 227 (146 and 81 active smokers hospitalized for HD and RD, respectively). All participants received smoking cessation treatment during hospitalization and were followed in a cognitive-behavioral smoking cessation program for six months after hospital discharge. Results: There were significant differences between the HD group and the RD group regarding participation in the cognitive-behavioral program after hospital discharge (13.0% vs. 35.8%; p = 0.003); smoking cessation at the end of follow-up (29% vs. 31%; p < 0.001); and the use of nicotine replacement therapy (3.4% vs. 33.3%; p < 0.001). No differences were found between the HD group and the RD group regarding the use of bupropion (11.0% vs. 12.3%; p = 0.92). Varenicline was used by only 0.7% of the patients in the HD group. Conclusions: In our sample, smoking cessation rates at six months after hospital discharge were higher among the patients with RD than among those with HD, as were treatment adherence rates. The implementation of smoking cessation programs for hospitalized patients with different diseases, delivered by the health care teams that treat these patients, is necessary for greater effectiveness in smoking cessation.

Sign in / Sign up

Export Citation Format

Share Document